761 related articles for article (PubMed ID: 36389420)
1. Investigation of the potential mechanism of the Shugan Xiaozhi decoction for the treatment of nonalcoholic fatty liver disease based on network pharmacology, molecular docking and molecular dynamics simulation.
Yang R; Yang H; Jiang D; Xu L; Feng L; Xing Y
PeerJ; 2022; 10():e14171. PubMed ID: 36389420
[TBL] [Abstract][Full Text] [Related]
2. An herbal formulation "Shugan Xiaozhi decoction" ameliorates methionine/choline deficiency-induced nonalcoholic steatohepatitis through regulating inflammation and apoptosis-related pathways.
Wang S; Chen B; Du R; Zhong M; Zhang C; Jin X; Cui X; Zhou Y; Kang Q; Xu H; Li Y; Wu Q; Tong G; Luo L
J Ethnopharmacol; 2024 Jul; 329():118127. PubMed ID: 38583728
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanism of Fufang Zhenzhu Tiaozhi capsule in the treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease based on network pharmacology and validation in minipigs.
Wang H; Tan H; Zhan W; Song L; Zhang D; Chen X; Lin Z; Wang W; Yang Y; Wang L; Bei W; Guo J
J Ethnopharmacol; 2021 Jun; 274():114056. PubMed ID: 33771638
[TBL] [Abstract][Full Text] [Related]
4. Integration of Network Pharmacology and Molecular Docking Technology Reveals the Mechanism of the Therapeutic Effect of Xixin Decoction on Alzheimer's Disease.
Zhang Z; Xu J; Ma S; Lin N; Hou M; Wei M; Li T; Shi J
Comb Chem High Throughput Screen; 2022; 25(10):1785-1804. PubMed ID: 35616676
[TBL] [Abstract][Full Text] [Related]
5. Study on the action mechanism of the Polygonum perfoliatum L. on non-alcoholic fatty liver disease, based on network pharmacology and experimental validation.
Liu G; Yang L; Tang Y; Lin J; Wang F; Shen J; Chang B; Kong X
J Ethnopharmacol; 2024 Jan; 319(Pt 3):117330. PubMed ID: 37863399
[TBL] [Abstract][Full Text] [Related]
6. Discussion on the molecular mechanism of Duhuo Jisheng decoction in treating osteoarthritis based on network pharmacology and molecular docking.
Yang L; Zheng S; Hou A; Wang S; Zhang J; Yu H; Wang X; Lan W
Medicine (Baltimore); 2022 Oct; 101(42):e31009. PubMed ID: 36281111
[TBL] [Abstract][Full Text] [Related]
7. The Network Pharmacology Study of Dahuang Fuzi Decoction for Treating Incomplete Intestinal Obstruction.
Guo JF; Zhao YT; Du QY; Ren Y; Wang Y; Wang ZX; Jin W
Biomed Res Int; 2022; 2022():2775434. PubMed ID: 35528155
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of Cynarine for treatment of non-alcoholic fatty liver disease based on the integration of network pharmacology, molecular docking and cell experiment.
Sun CY; Yang LL; Zhao P; Yan PZ; Li J; Zhao DS
Hereditas; 2022 Dec; 159(1):44. PubMed ID: 36451177
[TBL] [Abstract][Full Text] [Related]
9. [Mechanism of Sijunzi Decoction in treatment of Alzheimer's disease based on UPLC-Q-TOF-MS, network pharmacology, and experimental verification].
Cai KZ; Zheng Q; Zhu XD; Wei SF; Wu MQ; Xiong H; Zhao HT
Zhongguo Zhong Yao Za Zhi; 2023 Mar; 48(6):1620-1631. PubMed ID: 37005850
[TBL] [Abstract][Full Text] [Related]
10. Exploring the Potential Molecular Mechanism of the Shugan Jieyu Capsule in the Treatment of Depression through Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation.
Liu Z; Huang H; Yu Y; Jia Y; Li L; Shi X; Wang F
Curr Comput Aided Drug Des; 2024; 20(5):501-517. PubMed ID: 37340752
[TBL] [Abstract][Full Text] [Related]
11. Yangyinghuoxue decoction exerts a treatment effect on hepatic fibrosis by PI3K/AKT pathway in rat model: based on the network pharmacology and molecular docking.
Bai YM; Liang S; Zhou B
Aging (Albany NY); 2024 Feb; 16(4):3773-3789. PubMed ID: 38364259
[TBL] [Abstract][Full Text] [Related]
12. Network pharmacology prediction and molecular docking-based strategy to discover the potential pharmacological mechanism of Huang-Qi-Gui-Zhi-Wu-Wu decoction against deep vein thrombosis.
Fan W; Lan S; Yang Y; Liang J
J Orthop Surg Res; 2023 Jun; 18(1):475. PubMed ID: 37391801
[TBL] [Abstract][Full Text] [Related]
13. Research on the Mechanism of Qushi Huayu Decoction in the Intervention of Nonalcoholic Fatty Liver Disease Based on Network Pharmacology and Molecular Docking Technology.
Gao SS; Sun JJ; Wang X; Hu YY; Feng Q; Gou XJ
Biomed Res Int; 2020; 2020():1704960. PubMed ID: 33204683
[TBL] [Abstract][Full Text] [Related]
14. A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway.
Lin F; Zhang G; Yang X; Wang M; Wang R; Wan M; Wang J; Wu B; Yan T; Jia Y
J Ethnopharmacol; 2023 Mar; 303():115933. PubMed ID: 36403742
[TBL] [Abstract][Full Text] [Related]
15. Prediction and verification of the active ingredients and potential targets of Erhuang Quzhi Granules on non-alcoholic fatty liver disease based on network pharmacology.
Li S; Wu X; Ma Y; Zhang H; Chen W
J Ethnopharmacol; 2023 Jul; 311():116435. PubMed ID: 37023836
[TBL] [Abstract][Full Text] [Related]
16. [Mechanism of Danggui Sini Decoction in treatment of primary dysmenorrhea based on network pharmacology and molecular docking].
Que DH; Chen WH; Jiang FP; Pan F; Yang K
Zhongguo Zhong Yao Za Zhi; 2021 Feb; 46(4):855-864. PubMed ID: 33645090
[TBL] [Abstract][Full Text] [Related]
17. Network pharmacology-based prediction and validation of the active ingredients and potential mechanisms of the Huangxiong formula for treating ischemic stroke.
Zhao S; Zhang P; Yan Y; Xu W; Li J; Wang L; Wang N; Huang Y
J Ethnopharmacol; 2023 Aug; 312():116507. PubMed ID: 37080367
[TBL] [Abstract][Full Text] [Related]
18. Network pharmacology and molecular docking-based analyses to predict the potential mechanism of Huangqin decoction in treating colorectal cancer.
Li YJ; Tang DX; Yan HT; Yang B; Yang Z; Long FX
World J Clin Cases; 2023 Jul; 11(19):4553-4566. PubMed ID: 37469733
[TBL] [Abstract][Full Text] [Related]
19. Exploration of the possible mechanisms of Ling Gui Zhu Gan decoction in nephrotic syndrome based on network pharmacology, molecular docking and molecular dynamics simulation.
Shi L; Deng Y; Luo D; Li L; Kuang X; Qi A; Fu B
Medicine (Baltimore); 2023 Jul; 102(29):e34446. PubMed ID: 37478256
[TBL] [Abstract][Full Text] [Related]
20. Active ingredients and molecular targets of
Zheng Y; Ji S; Li X; Feng Q
PeerJ; 2022; 10():e13737. PubMed ID: 35873910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]